All In Biotech

Drug Trial Radar · NCT07528053

A Phase 1 Clinical Study of BW-20805-2-1001 in Healthy Participants

A Phase 1, Open-Label, Single Dose Bridging Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered BW-20805-2 in Healthy Participants

Last checked: Nov 20, 2026Latest source record: Apr 21, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

24

Planned (sponsor's estimate)

Start

Apr 28, 2026

Primary completion

Jun 30, 2026

Study completion Nov 5, 2027

Sponsor

Sponsor type
Industry
First posted
Apr 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 60 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

A Phase 1 Clinical Study Of BW-20805-2-1001 in Healthy Participants

Conditions

  • HV

Interventions

  • BW-20805Drug

    Cohort 1 will receive SC administrations of BW-20805 on Day1.

  • BW-20805Drug

    Group 2 will receive SC administrations of BW-20805 on Day1

  • BW-20805-2Drug

    Group 3 will receive SC administrations of BW-20805-2 on Day1.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Primary EndpointsTime frame: week 48

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Argo Investigative Site

    Melbourne, Victoria, Australia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.